Shi Zihai, Deputy Director of the National Healthcare Security Administration (NHSA), recently led a team to Tianjin to study the centralised procurement of high-value medical consumables by state organisations. He commented that it was necessary to speed up the work of the new batch of centralised procurement for high-value medical consumables by state organisations. High-value medical consumables such as cochlear implants should be included in the scope of the procurement. Taking full account of the market for the consumables and the clinical characteristics, rules for the centralised procurement shall be improved by studying the principle of "one product, one policy".Related NewsSINOPHARM (01099.HK) 1-3Q NP Wanes 13.4% YoY to RMB5.28BAt the same time, he directed to implement the results of the fourth batch of centralised procurement for consumables and the successive procurement of artificial joints upon the expiry of the previous agreement, so as to ensure that the selected products would be introduced to hospitals in a timely manner. Medical institutions should be guided and supervised to give priority to the procurement of the selected products, ensuring that the people will benefit in a practical way.